List of Tables
Table 1. Heparin CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
Table 2. Heparin Market Trends
Table 3. Heparin Market Drivers
Table 4. Heparin Market Challenges
Table 5. Heparin Market Restraints
Table 6. Global Heparin Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. India Heparin Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Heparin Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. India Heparin Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Manufacturers of Heparin, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Heparin Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Heparin Revenue Share by Manufacturer, 2018-2023
Table 13. Global Heparin Sales by Manufacturer, (B Units), 2018-2023
Table 14. Global Heparin Sales Share by Manufacturer, 2018-2023
Table 15. Global Heparin Price by Manufacturer (2018-2023) & (US$/B Units)
Table 16. Global Heparin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin as of 2022)
Table 18. Global Key Manufacturers of Heparin, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Heparin, Product Offered and Application
Table 20. Global Key Manufacturers of Heparin, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Heparin in India, Ranked by Revenue (2022) & (US$ million)
Table 23. India Heparin Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Heparin Revenue Share by Players, (2018-2023)
Table 25. India Heparin Sales by Players, (B Units), (2018-2023)
Table 26. India Heparin Sales Share by Players, (2018-2023)
Table 27. Global Heparin Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 28. Global Heparin Sales in Volume by Region (2018-2023) & (B Units)
Table 29. Global Heparin Sales in Volume Forecast by Region (2024-2029) & (B Units)
Table 30. Global Heparin Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Heparin Sales in Value Forecast by Region (2024-2029) & (US$ Million)
Table 32. Americas Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. Americas Heparin Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Heparin Sales in Value by Country (2024-2029) & (US$ Million)
Table 35. Americas Heparin Sales in Volume by Country (2018-2023) & (B Units)
Table 36. Americas Heparin Sales in Volume by Country (2024-2029) & (B Units)
Table 37. EMEA Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. EMEA Heparin Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Heparin Sales in Value by Country (2024-2029) & (US$ Million)
Table 40. EMEA Heparin Sales in Volume by Country (2018-2023) & (B Units)
Table 41. EMEA Heparin Sales in Volume by Country (2024-2029) & (B Units)
Table 42. APAC Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. APAC Heparin Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Heparin Sales in Value by Country (2024-2029) & (US$ Million)
Table 45. APAC Heparin Sales in Volume by Country (2018-2023) & (B Units)
Table 46. APAC Heparin Sales in Volume by Country (2024-2029) & (B Units)
Table 47. Shenzhen Hepalink Pharmaceutical Company Information
Table 48. Shenzhen Hepalink Pharmaceutical Description and Business Overview
Table 49. Shenzhen Hepalink Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 50. Shenzhen Hepalink Pharmaceutical Heparin Product
Table 51. Shenzhen Hepalink Pharmaceutical Recent Development
Table 52. Yantai Dongcheng Pharmaceutical Company Information
Table 53. Yantai Dongcheng Pharmaceutical Description and Business Overview
Table 54. Yantai Dongcheng Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 55. Yantai Dongcheng Pharmaceutical Heparin Product
Table 56. Yantai Dongcheng Pharmaceutical Recent Development
Table 57. Nanjing King-friend Biochemical Pharmaceutical Company Information
Table 58. Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
Table 59. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 60. Nanjing King-friend Biochemical Pharmaceutical Heparin Product
Table 61. Nanjing King-friend Biochemical Pharmaceutical Recent Development
Table 62. Pfizer Company Information
Table 63. Pfizer Description and Business Overview
Table 64. Pfizer Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 65. Pfizer Heparin Product
Table 66. Pfizer Recent Development
Table 67. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 68. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
Table 69. Hebei Changshan Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 70. Hebei Changshan Biochemical Pharmaceutical Heparin Product
Table 71. Hebei Changshan Biochemical Pharmaceutical Recent Development
Table 72. Bioibérica Company Information
Table 73. Bioibérica Description and Business Overview
Table 74. Bioibérica Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 75. Bioibérica Heparin Product
Table 76. Bioibérica Recent Development
Table 77. Qingdao Jiulong Biopharmaceutical Company Information
Table 78. Qingdao Jiulong Biopharmaceutical Description and Business Overview
Table 79. Qingdao Jiulong Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 80. Qingdao Jiulong Biopharmaceutical Heparin Product
Table 81. Qingdao Jiulong Biopharmaceutical Recent Development
Table 82. Changzhou Qianhong Biopharma Company Information
Table 83. Changzhou Qianhong Biopharma Description and Business Overview
Table 84. Changzhou Qianhong Biopharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 85. Changzhou Qianhong Biopharma Heparin Product
Table 86. Changzhou Qianhong Biopharma Recent Development
Table 87. Dongying Tiandong Pharmaceutical Company Information
Table 88. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 89. Dongying Tiandong Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 90. Dongying Tiandong Pharmaceutical Heparin Product
Table 91. Dongying Tiandong Pharmaceutical Recent Development
Table 92. Opocrin Company Information
Table 93. Opocrin Description and Business Overview
Table 94. Opocrin Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 95. Opocrin Heparin Product
Table 96. Opocrin Recent Development
Table 97. Hubei Enoray Biopharmaceutical Company Information
Table 98. Hubei Enoray Biopharmaceutical Description and Business Overview
Table 99. Hubei Enoray Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 100. Hubei Enoray Biopharmaceutical Heparin Product
Table 101. Hubei Enoray Biopharmaceutical Recent Development
Table 102. Yino Pharma Company Information
Table 103. Yino Pharma Description and Business Overview
Table 104. Yino Pharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 105. Yino Pharma Heparin Product
Table 106. Yino Pharma Recent Development
Table 107. Cisen Pharmaceutical Company Information
Table 108. Cisen Pharmaceutical Description and Business Overview
Table 109. Cisen Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 110. Cisen Pharmaceutical Heparin Product
Table 111. Cisen Pharmaceutical Recent Development
Table 112. Nanjing Xinbai Pharmaceutical Company Information
Table 113. Nanjing Xinbai Pharmaceutical Description and Business Overview
Table 114. Nanjing Xinbai Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 115. Nanjing Xinbai Pharmaceutical Heparin Product
Table 116. Nanjing Xinbai Pharmaceutical Recent Development
Table 117. Sichuan Deebio Pharmaceutical Company Information
Table 118. Sichuan Deebio Pharmaceutical Description and Business Overview
Table 119. Sichuan Deebio Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2018-2023)
Table 120. Sichuan Deebio Pharmaceutical Heparin Product
Table 121. Sichuan Deebio Pharmaceutical Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Heparin Customers List
Table 125. Heparin Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin Product Picture
Figure 2. Global Heparin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Heparin Market Size 2018-2029 (US$ Million)
Figure 4. Global Heparin Sales 2018-2029 (B Units)
Figure 5. India Heparin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 6. India Heparin Market Size 2018-2029 (US$ Million)
Figure 7. India Heparin Sales 2018-2029 (B Units)
Figure 8. India Heparin Market Share in Global, in Value (US$ Million) 2018-2029
Figure 9. India Heparin Market Share in Global, in Volume (B Units) 2018-2029
Figure 10. Heparin Report Years Considered
Figure 11. Product Picture of Heparin Sodium
Figure 12. Product Picture of Heparin Calcium
Figure 13. Global Heparin Market Share by Type in 2022 & 2029
Figure 14. Global Heparin Sales in Value by Type (2018-2029) & (US$ Million)
Figure 15. Global Heparin Sales Market Share in Value by Type (2018-2029)
Figure 16. Global Heparin Sales by Type (2018-2029) & (B Units)
Figure 17. Global Heparin Sales Market Share in Volume by Type (2018-2029)
Figure 18. Global Heparin Price by Type (2018-2029) & (US$/B Units)
Figure 19. India Heparin Market Share by Type in 2022 & 2029
Figure 20. India Heparin Sales in Value by Type (2018-2029) & (US$ Million)
Figure 21. India Heparin Sales Market Share in Value by Type (2018-2029)
Figure 22. India Heparin Sales by Type (2018-2029) & (B Units)
Figure 23. India Heparin Sales Market Share in Volume by Type (2018-2029)
Figure 24. India Heparin Price by Type (2018-2029) & (US$/B Units)
Figure 25. Product Picture of UFH
Figure 26. Product Picture of LMWH
Figure 27. Global Heparin Market Share by Application in 2022 & 2029
Figure 28. Global Heparin Sales in Value by Application (2018-2029) & (US$ Million)
Figure 29. Global Heparin Sales Market Share in Value by Application (2018-2029)
Figure 30. Global Heparin Sales by Application (2018-2029) & (B Units)
Figure 31. Global Heparin Sales Market Share in Volume by Application (2018-2029)
Figure 32. Global Heparin Price by Application (2018-2029) & (US$/B Units)
Figure 33. India Heparin Market Share by Application in 2022 & 2029
Figure 34. India Heparin Sales in Value by Application (2018-2029) & (US$ Million)
Figure 35. India Heparin Sales Market Share in Value by Application (2018-2029)
Figure 36. India Heparin Sales by Application (2018-2029) & (B Units)
Figure 37. India Heparin Sales Market Share in Volume by Application (2018-2029)
Figure 38. India Heparin Price by Application (2018-2029) & (US$/B Units)
Figure 39. Americas Heparin Sales in Volume Growth Rate 2018-2029 (B Units)
Figure 40. Americas Heparin Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 41. Americas Heparin Sales by Type (2018-2029) & (B Units)
Figure 42. Americas Heparin Sales Market Share in Volume by Type (2018-2029)
Figure 43. Americas Heparin Sales by Application (2018-2029) & (B Units)
Figure 44. Americas Heparin Sales Market Share in Volume by Application (2018-2029)
Figure 45. United States Heparin Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 46. Canada Heparin Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 47. Mexico Heparin Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Heparin Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 49. EMEA Heparin Sales in Volume Growth Rate 2018-2029 (B Units)
Figure 50. EMEA Heparin Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 51. EMEA Heparin Sales by Type (2018-2029) & (B Units)
Figure 52. EMEA Heparin Sales Market Share in Volume by Type (2018-2029)
Figure 53. EMEA Heparin Sales by Application (2018-2029) & (B Units)
Figure 54. EMEA Heparin Sales Market Share in Volume by Application (2018-2029)
Figure 55. Europe Heparin Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 56. Middle East Heparin Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 57. Africa Heparin Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 58. China Heparin Sales in Volume Growth Rate 2018-2029 (B Units)
Figure 59. China Heparin Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 60. China Heparin Sales by Type (2018-2029) & (B Units)
Figure 61. China Heparin Sales Market Share in Volume by Type (2018-2029)
Figure 62. China Heparin Sales by Application (2018-2029) & (B Units)
Figure 63. China Heparin Sales Market Share in Volume by Application (2018-2029)
Figure 64. APAC Heparin Sales in Volume Growth Rate 2018-2029 (B Units)
Figure 65. APAC Heparin Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 66. APAC Heparin Sales by Type (2018-2029) & (B Units)
Figure 67. APAC Heparin Sales Market Share in Volume by Type (2018-2029)
Figure 68. APAC Heparin Sales by Application (2018-2029) & (B Units)
Figure 69. APAC Heparin Sales Market Share in Volume by Application (2018-2029)
Figure 70. Japan Heparin Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 71. South Korea Heparin Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 72. China Taiwan Heparin Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 73. Southeast Asia Heparin Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 74. India Heparin Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 75. Heparin Value Chain
Figure 76. Heparin Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
